Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

VRCA

Verrica Parmaceuticals (VRCA)

Verrica Parmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:VRCA
DateHeureSourceTitreSymboleSociété
10/06/202422h18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VRCAVerrica Parmaceuticals Inc
07/06/202422h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VRCAVerrica Parmaceuticals Inc
13/05/202422h31Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:VRCAVerrica Parmaceuticals Inc
13/05/202414h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VRCAVerrica Parmaceuticals Inc
29/02/202414h05Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:VRCAVerrica Parmaceuticals Inc
16/11/202316h28Edgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:VRCAVerrica Parmaceuticals Inc
15/11/202322h54Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VRCAVerrica Parmaceuticals Inc
22/07/202301h28Dow Jones NewsStocks to Watch: AMC Entertainment, Becton Dickinson and Verrica PharmaceuticalsNASDAQ:VRCAVerrica Parmaceuticals Inc
21/07/202323h05Dow Jones NewsVerrica Pharmaceuticals' Molluscum Contagiosum Topical Solution Gets FDA ApprovalNASDAQ:VRCAVerrica Parmaceuticals Inc
12/06/202315h05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRCAVerrica Parmaceuticals Inc
08/06/202322h17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VRCAVerrica Parmaceuticals Inc
09/05/202314h28Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VRCAVerrica Parmaceuticals Inc
09/05/202314h22Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:VRCAVerrica Parmaceuticals Inc
21/04/202314h57Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:VRCAVerrica Parmaceuticals Inc
21/04/202314h51Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:VRCAVerrica Parmaceuticals Inc
21/04/202314h46Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:VRCAVerrica Parmaceuticals Inc
06/03/202315h41Edgar (US Regulatory)Annual Report (10-k)NASDAQ:VRCAVerrica Parmaceuticals Inc
22/02/202322h18Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:VRCAVerrica Parmaceuticals Inc
14/02/202320h37Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VRCAVerrica Parmaceuticals Inc
20/12/202212h10Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:VRCAVerrica Parmaceuticals Inc
14/11/202212h15TipRanksH.C. Wainwright Remains a Buy on Verrica Pharmaceuticals (VRCA)NASDAQ:VRCAVerrica Parmaceuticals Inc
11/11/202202h48TipRanksRBC Capital Remains a Hold on Verrica Pharmaceuticals (VRCA)NASDAQ:VRCAVerrica Parmaceuticals Inc
07/11/202223h23Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:VRCAVerrica Parmaceuticals Inc
07/11/202222h05GlobeNewswire Inc.Verrica Pharmaceuticals Reports Third Quarter 2022 Financial ResultsNASDAQ:VRCAVerrica Parmaceuticals Inc
31/08/202222h30GlobeNewswire Inc.Verrica Pharmaceuticals Announces Participation in the H.C. Wainwright 24th Annual Global Investment ConferenceNASDAQ:VRCAVerrica Parmaceuticals Inc
12/08/202212h25TipRanksH.C. Wainwright Keeps Their Buy Rating on Verrica Pharmaceuticals (VRCA)NASDAQ:VRCAVerrica Parmaceuticals Inc
11/08/202222h35TipRanksNeedham Remains a Hold on Verrica Pharmaceuticals (VRCA)NASDAQ:VRCAVerrica Parmaceuticals Inc
11/08/202213h30GlobeNewswire Inc.Verrica Pharmaceuticals Reports Second Quarter 2022 Financial ResultsNASDAQ:VRCAVerrica Parmaceuticals Inc
05/08/202218h18PR Newswire (US)VRCA SHAREHOLDER ALERT: Jakubowitz Law Reminds Verrica Shareholders of a Lead Plaintiff Deadline of August 5, 2022NASDAQ:VRCAVerrica Parmaceuticals Inc
03/08/202211h45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Verrica Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 5, 2022 - (NASDAQ: VRCA)NASDAQ:VRCAVerrica Parmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:VRCA